Prenatal testosterone is considered to be a possible factor contributing to the development of attention-deficit/hyperactivity disorder (ADHD) symptomatology, but findings regarding the connection between individual variations in prenatal testosterone exposure as (indirectly) indexed by the second-to-fourth digit (2D:4D) ratio and ADHD remain inconsistent. To clarify the inconsistent findings and to facilitate generalization on the association between subclinical variations in ADHD tendencies and lower 2D:4D ratios the current study applied a cross-cultural replication approach employing independent healthy adult cohorts from Germany and China. Samples from Germany and China were matched for gender and age (in each sample n = 96, n = 96; age: M = 21.47, SD = 2.55; age: M = 21.36, SD = 2.28). All participants filled in the Adult ADHD Self-Report Scale Symptom Checklist (ASRS) and provided hand scans to measure 2D:4D ratios. The German sample had significantly higher 2D:4D ratios than the Chinese sample but in both samples males had significantly lower 2D:4D ratios than females. The hypothesised negative association between 2D:4D ratios and ADHD tendencies was observed on a descriptive level in German and Chinese males and with one exception in Chinese females. But only in German males correlations gained significance (range: r = -0.198 to r = -0.177). The observed effect sizes are in line with former research that was conducted in samples from different cultures. In future research on the connection between testosterone and ADHD not only prenatal but also postnatal testosterone as well as possible moderators like childhood maltreatment should be taken into account.Copyright © 2020 Elsevier B.V. All rights reserved.
Angiotensin II contributes to intratumoral immunosuppressionvia induction of PD-L1 expression in non-small cell lung carcinoma.
April 28, 2020
May 5, 2020
“Long-term results of moderate hypofractionation to prostate and pelvic nodes plus androgen suppression in high-risk prostate cancer.”
August 3, 2020
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.
- AAN 2020Due to the global COVID-19 pandemic, the American Academy of Neurology had to cancel the AAN’s Annual Meeting originally scheduled for April 25–May 1, 2020, in Toronto.